Welcome!

News Feed Item

Entest BioMedical Inc. Recruits Salk Institute Researcher to Lead Cancer Stem Cell Program for Treating Feline Leukemia and Canine Cancer

SAN DIEGO, CA -- (Marketwired) -- 07/16/14 -- Entest BioMedical Inc. (PINKSHEETS: ENTB)

  • Dr. Christine Ichim to assist in the development of the Company's canine immunotherapy for the treatment of cancer
  • Dr. Ichim has done research on cancer stem cells for more than 14 years

Entest BioMedical Inc. (PINKSHEETS: ENTB) announced today that Dr. Christine Ichim has joined the Company as Its Director of Research. Dr. Ichim was previously with the Salk Institute where she conducted research in the areas of cancer and stem cell division, cell senescence and aging.

While at the University of Toronto, Dr. Ichim began developing research for the treatment of feline leukemia. Dr. Ichim has published her research in peer reviewed journals on immunological therapies for treating cancer. David Koos, Chairman & CEO of Entest BioMedical Inc. noted, "Dr. Ichim has a unique approach to treating leukemia and cancer. She is focused on cell senescence of cancer stem cells. This approach involves forcing cells that would normally become cancerous into a state of maturation where they no longer have the capacity to grow. Cancer cells typically have the ability to expand leading to life threatening conditions such as lung cancer. In this cell senescence approach, these cancer cells are no longer capable of expansion, thus rendering these cells harmless."

Dr. Ichim stated, "I am extremely excited about having the opportunity to apply my knowledge of cancer stem cells to treating leukemia in cats and cancer in dogs. While I was conducting research at the University of Toronto, I developed a model of treating cancer through forcing senescence in cancer stem cells. The next step is to develop animal therapies utilizing this model in veterinary treatments."

A spokesperson for the Company noted that it has spent an extensive period of time evaluating the most effective way to move forward in developing veterinary therapeutics. The Company believes that Dr. Ichim will be instrumental in this endeavor.

DISCLAIMER:
This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

About Entest BioMedical Inc.:
Entest BioMedical Inc. (PINKSHEETS: ENTB) is a developer of veterinary medicines that harness the animal's own reparative / immunological mechanisms. The Company is currently focused on developing therapies for treating feline leukemia and canine cancer.

About Christine Ichim, PhD:
Dr. Christine Ichim has 20 years of experience in immunology and cancer biology. Dr. Ichim obtained a PhD from the University of Toronto, in the Department of Medical Biophysics. She completed a Master of Science under the tutelage of Dr. Norman Iscove, where she studied the molecular biology of the leukemia stem cell. She completed a PhD focused on a novel oncogene that she identified to control leukemia stem cells. Dr. Ichim completed postdoctoral training at the Salk Institute for Biological Studies, where she conducted research on DNA biology relevant to cell division. This work was funded by the Canadian Institutes of Health Research (CIHR). She has numerous peer reviewed articles including:

The orphan nuclear receptor Ear-2 (Nr2f6) is a novel negative regulator of T cell development.
http://www.ncbi.nlm.nih.gov/pubmed/24096122

Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.
http://www.ncbi.nlm.nih.gov/pubmed/15698481

Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitors.
http://www.ncbi.nlm.nih.gov/pubmed/24598782

Identification of a role for the nuclear receptor EAR-2 in the maintenance of clonogenic status within the leukemia cell hierarchy.
http://www.ncbi.nlm.nih.gov/pubmed/21637284

First among equals: the cancer cell hierarchy.
http://www.ncbi.nlm.nih.gov/pubmed/17071472

Contact Entest BioMedical Inc.

David R. Koos
Chairman & CEO

619.702.1404 Direct
619.330.2328 Fax
Email Contact
www.EntestBio.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Pentaho has announced orchestration capabilities that streamline the entire machine learning workflow and enable teams of data scientists, engineers and analysts to train, tune, test and deploy predictive models. Pentaho’s Data Integration and analytics platform ends the ‘gridlock’ associated with machine learning by enabling smooth team collaboration, maximizing limited data science resources and putting predictive models to work on big data faster – regardless of use case, industry, or languag...
SYS-CON Events announced today that T-Mobile will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. As America's Un-carrier, T-Mobile US, Inc., is redefining the way consumers and businesses buy wireless services through leading product and service innovation. The Company's advanced nationwide 4G LTE network delivers outstanding wireless experiences to 67.4 million customers who are unwilling to compromise on ...
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
SYS-CON Events announced today that Loom Systems will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2015, Loom Systems delivers an advanced AI solution to predict and prevent problems in the digital business. Loom stands alone in the industry as an AI analysis platform requiring no prior math knowledge from operators, leveraging the existing staff to succeed in the digital era. With offices in S...
SYS-CON Events announced today that Addteq will exhibit at SYS-CON's DevOps Summit at Cloud Expo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Addteq specializes in creating innovative solutions to solve business processes through the use of DevOps automation. Addteq was founded on the firm belief that automation is essential for successful software releases. Addteq's products and services are centered around the fundamental approach of understanding the pr...
Keeping pace with advancements in software delivery processes and tooling is taxing even for the most proficient organizations. Point tools, platforms, open source and the increasing adoption of private and public cloud services requires strong engineering rigor - all in the face of developer demands to use the tools of choice. As Agile has settled in as a mainstream practice, now DevOps has emerged as the next wave to improve software delivery speed and output. To make DevOps work, organization...
SYS-CON Events announced today that Juniper Networks (NYSE: JNPR), an industry leader in automated, scalable and secure networks, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. The company co-innovates with customers and partners to deliver automated, scalable and secure network...
Peak 10 has announced that it has completed a 20,000 square foot expansion of its Cincinnati-area data center, a 6,000 square foot expansion of its data center campus in Charlotte’s University Research Park, and added a pair of seasoned executives to its leadership team. This further propels the company on its aggressive growth trajectory to meet the rising demand for flexible hybrid IT strategies and solutions across its enterprise customer base. Cincinnati is home to companies like Kroger, Pr...
VeriStor Systems has announced that CRN has named VeriStor to its 2017 Managed Service Provider (MSP) 500 list in the Elite 150 category. This annual list recognizes North American solution providers with cutting-edge approaches to delivering managed services. Their offerings help companies navigate the complex and ever-changing landscape of IT, improve operational efficiencies, and maximize their return on IT investments. In today’s fast-paced business environments, MSPs play an important role...
SYS-CON Events announced today that Cloudistics, an on-premises cloud computing company, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloudistics delivers a complete public cloud experience with composable on-premises infrastructures to medium and large enterprises. Its software-defined technology natively converges network, storage, compute, virtualization, and management into a ...
SYS-CON Events announced today that Infranics will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Since 2000, Infranics has developed SysMaster Suite, which is required for the stable and efficient management of ICT infrastructure. The ICT management solution developed and provided by Infranics continues to add intelligence to the ICT infrastructure through the IMC (Infra Management Cycle) based on mathemat...
Virtualization over the past years has become a key strategy for IT to acquire multi-tenancy, increase utilization, develop elasticity and improve security. And virtual machines (VMs) are quickly becoming a main vehicle for developing and deploying applications. The introduction of containers seems to be bringing another and perhaps overlapped solution for achieving the same above-mentioned benefits. Are a container and a virtual machine fundamentally the same or different? And how? Is one techn...
Have you ever noticed how some IT people seem to lead successful, rewarding, and satisfying lives and careers, while others struggle? IT author and speaker Don Crawley uncovered the five principles that successful IT people use to build satisfying lives and careers and he shares them in this fast-paced, thought-provoking webinar. You'll learn the importance of striking a balance with technical skills and people skills, challenge your pre-existing ideas about IT customer service, and gain new in...
"I think that everyone recognizes that for IoT to really realize its full potential and value that it is about creating ecosystems and marketplaces and that no single vendor is able to support what is required," explained Esmeralda Swartz, VP, Marketing Enterprise and Cloud at Ericsson, in this SYS-CON.tv interview at @ThingsExpo, held June 7-9, 2016, at the Javits Center in New York City, NY.
The buzz continues for cloud, data analytics and the Internet of Things (IoT) and their collective impact across all industries. But a new conversation is emerging - how do companies use industry disruption and technology enablers to lead in markets undergoing change, uncertainty and ambiguity? Organizations of all sizes need to evolve and transform, often under massive pressure, as industry lines blur and merge and traditional business models are assaulted and turned upside down. In this new da...